Genomic answers for Early Onset Epilepsy

On 14 July 2022 the North Thames Genomic Medicine Service (GMS) held an event showcasing how genomic medicine is transforming healthcare in our region.

Around 1 in 1000 children develop early onset epilepsy, and 50% of cases are believed to have a genetic cause. Determining this genetic cause can have a major impact on treatment considerations. In this talk Professor Helen Cross, The Prince of Wales’s Chair of Childhood Epilepsy and Head of the Developmental Neuroscience Research and Teaching Department at UCL-Great Ormond Street Institute of Child Health, provides an overview of the ongoing GeneSTEPS study – Shortening Time to Evaluation in Paediatric Epilepsy Services – which aims to determine genetic answers for early onset epilepsy.